• News

    HDA and PCSC Announce Launch of GDP Accreditation Program

    April 04, 2024

    The HDA announced the launch of its Good Distribution Practices (GDP) Accreditation Program through the association’s Pharmaceutical Cargo Security Coalition (PCSC) at the annual PCSC Educational Seminar held in Whippany, N.J. ASC Associates Ltd, a European-based firm with extensive experience developing and implementing GDP training programs consistent with those in Europe, the only recognized standards globally, will help administer the program.

  • News

    HDA Pharmaceutical Cargo Security Coalition Honors Supply Chain Security Experts

    April 04, 2024

    The HDA Pharmaceutical Cargo Security Coalition (PCSC) honored three security leaders at the annual PCSC Educational Seminar in Whippany, N.J. The PCSC Award is given to supply chain security professionals for distinguished service consistent with the highest traditions of private and public sector safety and security.

  • News

    HDA Presents 2024 Distribution Management Award to Apotex

    March 11, 2024

    HDA honored Apotex Corp. with the 2024 Distribution Management Award (DMA) for the company’s work to import cisplatin during the 2024 Distribution Management Conference and Expo in Palm Desert, California.

  • News

    HDA Honors Pharmaceutical Supply Chain Leader Jane Kogut Keyser with DMA for Industry Leadership

    March 11, 2024

    HDA honored Jane Kogut Keyser of Bristol Myers Squibb with the Distribution Management Award (DMA) for Industry Leadership at its annual Distribution Management Conference and Expo in Palm Desert, California.   

  • News

    HDA Statement on Change Healthcare Cyberattack

    March 08, 2024

    The Healthcare Distribution Alliance (HDA) released a statement regarding the recent cyberattack on Change Healthcare.

  • News

    HDA Research Foundation Explores Challenges and Opportunities of Cold Chain Product Distribution

    March 07, 2024

    A new publication released by the HDA Research Foundation and Envision Pharma Group — The Future of the U.S. Pharmaceutical Cold Chain — offers strategies to address the remarkable growth of temperature-sensitive products in the healthcare ecosystem — a product class that, as noted in the report, has outpaced non-cold chain therapies by 21 percent between 2018 and 2024.

Media Contacts

John Parker
Senior Vice President, Communications and Marketing

Farah Simonett
Vice President, Communications and Marketing

Elizabeth Baker
Director, Communications